NFKB1 and COVID-19: demonstrated a significant increase in TNF-α and NF-κB expression in postmortem lung samples of patients who died of ARDS due to COVID-19 compared to the control group that died due to neoplastic or cardiovascular disease without the presence of lung lesions (Miggiolaro et al., 2023).